MoneyWorks4Me

Abbott India informs about change in management

03 Feb 2025 Evaluate
With reference to earlier communication dated January 21, 2025, wherein the Company had informed that Kunal Chowdhury - Commercial Director - GI Businesses has been promoted to another affiliate of the company effective February 1, 2025. Accordingly, he has served his role as Commercial Director - GI Businesses with the company until January 31, 2025. Further to the above communication and pursuant to Regulation 30 read with Clause 7C of Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Abbott India has informed that it enclosed the letter received from Kunal Chowdhury.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..